Literature DB >> 16982858

Cutting edge: T cell requirement for CD28 costimulation is due to negative regulation of TCR signals by PTEN.

Jodi L Buckler1, Patrick T Walsh, Paige M Porrett, Yongwon Choi, Laurence A Turka.   

Abstract

Recent studies suggest that the phosphatase and tensin homolog deleted on chromosome 10 (PTEN) plays a critical role in the maintenance of self-tolerance. Using T cell-specific PTEN knockout mice (PTENDeltaT), we have identified a novel mechanism by which PTEN regulates T cell tolerance. We found that TCR stimulation alone, without CD28 costimulation, is sufficient to induce hyperactivation of the PI3K pathway, which leads to enhanced IL-2 production by naive PTENDeltaT T cells. Importantly, as a result of this increased response to TCR stimulation, PTENDeltaT CD4(+) T cells no longer require CD28 costimulation for in vitro or in vivo expansion. In fact, unlike wild-type T cells, PTENDeltaT CD4(+) T cells are not anergized by delivery of TCR stimulation alone. These data suggest that by negatively regulating TCR signals, PTEN imposes a requirement for CD28 costimulation, thus defining a novel mechanism for its role in self-tolerance.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16982858     DOI: 10.4049/jimmunol.177.7.4262

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  44 in total

1.  E3 ubiquitin ligase Cbl-b regulates Pten via Nedd4 in T cells independently of its ubiquitin ligase activity.

Authors:  Hui Guo; Guilin Qiao; Haiyan Ying; Zhenping Li; Yixia Zhao; Yanran Liang; Lifen Yang; Stanley Lipkowitz; Josef M Penninger; Wallace Y Langdon; Jian Zhang
Journal:  Cell Rep       Date:  2012-05-31       Impact factor: 9.423

Review 2.  Interleukin-2 receptor downstream events in regulatory T cells: implications for the choice of immunosuppressive drug therapy.

Authors:  Robert Zeiser; Robert S Negrin
Journal:  Cell Cycle       Date:  2007-12-18       Impact factor: 4.534

Review 3.  The functions of tumor suppressor PTEN in innate and adaptive immunity.

Authors:  Lang Chen; Deyin Guo
Journal:  Cell Mol Immunol       Date:  2017-06-26       Impact factor: 11.530

4.  Splicing factor SRSF1 controls T cell hyperactivity and systemic autoimmunity.

Authors:  Takayuki Katsuyama; Hao Li; Denis Comte; George C Tsokos; Vaishali R Moulton
Journal:  J Clin Invest       Date:  2019-12-02       Impact factor: 14.808

5.  Analysis of the expression level and methylation of tumor protein p53, phosphatase and tensin homolog and mutS homolog 2 in N-methyl-N-nitrosourea-induced thymic lymphoma in C57BL/6 mice.

Authors:  Xueyun Huo; Zhenkun Li; Shuangyue Zhang; Changlong Li; Meng Guo; Jing Lu; Jianyi Lv; Xiaoyan Du; Zhenwen Chen
Journal:  Oncol Lett       Date:  2017-08-04       Impact factor: 2.967

6.  The role of the PI3K-AKT kinase pathway in T-cell development beyond the beta checkpoint.

Authors:  Ling Xue; Leslie Chiang; Chulho Kang; Astar Winoto
Journal:  Eur J Immunol       Date:  2008-11       Impact factor: 5.532

7.  PTEN regulates natural killer cell trafficking in vivo.

Authors:  Jeffrey W Leong; Stephanie E Schneider; Ryan P Sullivan; Bijal A Parikh; Bryan A Anthony; Anvita Singh; Brea A Jewell; Timothy Schappe; Julia A Wagner; Daniel C Link; Wayne M Yokoyama; Todd A Fehniger
Journal:  Proc Natl Acad Sci U S A       Date:  2015-02-02       Impact factor: 11.205

8.  Antigen-induced Pten gene deletion in T cells exacerbates neuropathology in experimental autoimmune encephalomyelitis.

Authors:  Trina A Johnson; Shigeki Tsutsui; Frank R Jirik
Journal:  Am J Pathol       Date:  2008-03-18       Impact factor: 4.307

9.  An adenoviral vector encoding dominant negative Cbl lowers the threshold for T cell activation in post-thymic T cells.

Authors:  Yuanyuan Zha; Thomas F Gajewski
Journal:  Cell Immunol       Date:  2007-09-25       Impact factor: 4.868

10.  Phosphoinositide-dependent kinase 1 controls migration and malignant transformation but not cell growth and proliferation in PTEN-null lymphocytes.

Authors:  David K Finlay; Linda V Sinclair; Carmen Feijoo; Caryll M Waugh; Thijs J Hagenbeek; Hergen Spits; Doreen A Cantrell
Journal:  J Exp Med       Date:  2009-10-05       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.